Synopsis
The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA).
Agencies
In a regulatory filing, Dr Reddy s laboratories announced launch of Capecitabine tablets in the US.
The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA).
In a regulatory filing, Dr Reddy s laboratories announced launch of Capecitabine tablets in the US.
Quoting IQVIA Health data, Dr Reddy s said the Xeloda brand and generic had US sales of approximately USD 90 million for the most recent 12 months ending in October 2020.